Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000064 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
28,772
Total Value
$837,210.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 8,000 | $12.50 | $100,000.00 | 25,294 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 1,459 | $34.39 | $50,175.01 | 26,753 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jun 12, 2026 | Sale | 1,859 | $68.34 | $127,047.59 | 24,894 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jun 12, 2026 | Sale | 4,340 | $69.85 | $303,154.21 | 20,554 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jun 12, 2026 | Sale | 3,260 | $70.34 | $229,305.79 | 17,294 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jun 15, 2026 | Sale | 395 | $69.69 | $27,527.55 | 16,899 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 8,000 | $0.00 | $0.00 | 110,000 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Jun 12, 2026 | Exercise/Conversion | 1,459 | $0.00 | $0.00 | 62,708 | Direct | โ | View Details |